Physician
Victor O.A. Ogunlana MD PA
Victor O.A. Ogunlana MD PA was paid $4.27M by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoVICTOR O.A. OGUNLANA MD PA
MISSION, TX 78574
MISSION, TX 78574
33aNPI1942489943assigned 10/26/2007
33bProvider typePediatrics Physician
28Total paid$4.27M
24GClaims132,499
24DCodes billed68
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#102 of 1,136
Median peer was paid$329K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 97 | $2K | |
| 2019 | 116 | $4K | |
| 2020 | 2,825 | $68K | |
| 2021 | 31,255 | $896K | |
| 2022 | 38,151 | $1.50M | |
| 2023 | 32,770 | $1.02M | |
| 2024incomplete | 27,285 | $779K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 25,515 | 22,203 | $944K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 16% | 4,776 | 4,333 | $667K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.2% | 9,341 | 8,174 | $394K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.9% | 6,488 | 6,148 | $339K |
| 87428 | 6.9% | 7,709 | 6,865 | $296K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.4% | 3,485 | 3,398 | $275K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.7% | 2,943 | 2,889 | $243K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.5% | 2,237 | 2,183 | $191K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.1% | 16,455 | 7,263 | $176K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.0% | 2,267 | 2,188 | $172K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 3,604 | 3,401 | $89K |
| 99429 | 2.1% | 2,895 | 2,862 | $88K |
56 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 4,180 | $57K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 8,376 | $53K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 3,727 | $50K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 694 | $41K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,961 | $24K |
| 90461 | <1% | 2,223 | $17K | |
| 87807 | <1% | 1,560 | $16K | |
| 0071A | <1% | 409 | $16K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,329 | $15K |
| 0001A | <1% | 390 | $15K | |
| 99381 | <1% | 172 | $14K | |
| 0002A | <1% | 335 | $13K | |
| 99000 | <1% | 1,166 | $12K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 772 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 199 | $10K |
| 94010 | <1% | 310 | $7K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 69 | $6K |
| 0072A | <1% | 126 | $5K | |
| 0003A | <1% | 81 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 66 | $3K |
| 97169 | <1% | 52 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 28 | $2K |
| 81002 | <1% | 641 | $2K | |
| 0081A | <1% | 32 | $1K | |
| 99384 | <1% | 14 | $1K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 98 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 30 | $982.50 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 585 | $967.90 |
| 96160 | <1% | 623 | $502.00 | |
| 0031A | <1% | 19 | $400.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 139 | $365.92 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 163 | $231.29 |
| 86580 | <1% | 14 | $113.96 | |
| 90686 | <1% | 2,246 | $1.34 | |
| 90651 | <1% | 663 | $0.35 | |
| 90620 | <1% | 477 | $0.20 | |
| 90671 | <1% | 89 | $0.05 | |
| 90670 | <1% | 2,003 | $0.02 | |
| 90734 | 0% | 713 | $0.00 | |
| 90710 | 0% | 170 | $0.00 | |
| 91300 | 0% | 108 | $0.00 | |
| 90681 | 0% | 887 | $0.00 | |
| 90633 | 0% | 1,052 | $0.00 | |
| 90700 | 0% | 273 | $0.00 | |
| 90707 | 0% | 319 | $0.00 | |
| 90648 | 0% | 1,450 | $0.00 | |
| 90380 | 0% | 15 | $0.00 | |
| 91308 | 0% | 54 | $0.00 | |
| 90715 | 0% | 145 | $0.00 | |
| 90723 | 0% | 909 | $0.00 | |
| 90696 | 0% | 172 | $0.00 | |
| 91307 | 0% | 603 | $0.00 | |
| 90698 | 0% | 280 | $0.00 | |
| 90716 | 0% | 311 | $0.00 | |
| 90656 | 0% | 217 | $0.00 | |
| 90744 | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOGUNLANA, VICTOR (PRESIDENT)